Agios Pharmaceuticals, Inc. (AGIO)
USD 24.57
(-4.62%)
USD 24.57
(-4.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -391.48 Million USD | -0.63% |
| 2022 | -389.04 Million USD | -2.81% |
| 2021 | -378.41 Million USD | -19.7% |
| 2020 | -316.14 Million USD | 25.84% |
| 2019 | -426.33 Million USD | -17.62% |
| 2018 | -362.47 Million USD | -12.99% |
| 2017 | -320.79 Million USD | -59.61% |
| 2016 | -200.98 Million USD | -69.32% |
| 2015 | -118.7 Million USD | -119.27% |
| 2014 | -54.13 Million USD | -39.22% |
| 2013 | -38.88 Million USD | -69.09% |
| 2012 | -22.99 Million USD | -38.27% |
| 2011 | -16.63 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -105.81 Million USD | -14.93% |
| 2024 Q3 | -102.81 Million USD | 2.84% |
| 2024 Q1 | -92.07 Million USD | 13.37% |
| 2023 Q3 | -100.89 Million USD | -7.68% |
| 2023 Q1 | -90.61 Million USD | 8.63% |
| 2023 FY | -391.48 Million USD | -0.63% |
| 2023 Q2 | -93.7 Million USD | -3.41% |
| 2023 Q4 | -106.27 Million USD | -5.33% |
| 2022 Q4 | -99.17 Million USD | -8.87% |
| 2022 Q3 | -91.09 Million USD | 6.71% |
| 2022 Q2 | -97.64 Million USD | 3.47% |
| 2022 Q1 | -101.14 Million USD | 3.51% |
| 2022 FY | -389.04 Million USD | -2.81% |
| 2021 Q4 | -104.82 Million USD | -15.0% |
| 2021 Q1 | -91.21 Million USD | 1.32% |
| 2021 FY | -378.41 Million USD | -19.7% |
| 2021 Q2 | -91.22 Million USD | -0.01% |
| 2021 Q3 | -91.15 Million USD | 0.08% |
| 2020 Q4 | -92.43 Million USD | -2.33% |
| 2020 FY | -316.14 Million USD | 25.84% |
| 2020 Q1 | -43.19 Million USD | 59.23% |
| 2020 Q3 | -90.32 Million USD | -0.15% |
| 2020 Q2 | -90.19 Million USD | -108.83% |
| 2019 Q4 | -105.92 Million USD | 2.87% |
| 2019 Q2 | -113.86 Million USD | -16.8% |
| 2019 Q1 | -97.48 Million USD | -1.17% |
| 2019 FY | -426.33 Million USD | -17.62% |
| 2019 Q3 | -109.06 Million USD | 4.22% |
| 2018 Q2 | -72.94 Million USD | 22.4% |
| 2018 Q1 | -94.01 Million USD | -4.31% |
| 2018 Q4 | -96.35 Million USD | 2.83% |
| 2018 FY | -362.47 Million USD | -12.99% |
| 2018 Q3 | -99.16 Million USD | -35.93% |
| 2017 Q3 | -79.01 Million USD | 6.6% |
| 2017 Q4 | -90.13 Million USD | -14.06% |
| 2017 FY | -320.79 Million USD | -59.61% |
| 2017 Q1 | -67.04 Million USD | -16.79% |
| 2017 Q2 | -84.6 Million USD | -26.18% |
| 2016 Q1 | -23.59 Million USD | 42.31% |
| 2016 FY | -200.98 Million USD | -69.32% |
| 2016 Q3 | -63.51 Million USD | -12.47% |
| 2016 Q4 | -57.4 Million USD | 9.61% |
| 2016 Q2 | -56.47 Million USD | -139.34% |
| 2015 Q1 | -5.19 Million USD | 80.56% |
| 2015 FY | -118.7 Million USD | -119.27% |
| 2015 Q4 | -40.89 Million USD | -1.04% |
| 2015 Q3 | -40.47 Million USD | -25.96% |
| 2015 Q2 | -32.13 Million USD | -518.54% |
| 2014 Q2 | -18.33 Million USD | -49.22% |
| 2014 Q1 | -12.28 Million USD | -0.34% |
| 2014 FY | -54.13 Million USD | -39.22% |
| 2014 Q4 | -26.72 Million USD | -933.14% |
| 2014 Q3 | 3.2 Million USD | 117.5% |
| 2013 Q3 | -11.06 Million USD | -29.83% |
| 2013 Q2 | -8.52 Million USD | -21.0% |
| 2013 Q1 | -7.04 Million USD | -8.45% |
| 2013 FY | -38.88 Million USD | -69.09% |
| 2013 Q4 | -12.24 Million USD | -10.6% |
| 2012 FY | -22.99 Million USD | -38.27% |
| 2012 Q2 | -6.12 Million USD | -16.32% |
| 2012 Q3 | -5.11 Million USD | 16.54% |
| 2012 Q4 | -6.49 Million USD | -27.14% |
| 2012 Q1 | -5.26 Million USD | 0.0% |
| 2011 FY | -16.63 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -237.2 Million USD | -65.04% |
| Alkermes plc | 414.12 Million USD | 194.534% |
| Agenus Inc. | -159.54 Million USD | -145.371% |
| Aptorum Group Limited | -10.52 Million USD | -3620.182% |
| Ardelyx, Inc. | -63.27 Million USD | -518.697% |
| Dyadic International, Inc. | -8.22 Million USD | -4656.98% |
| Eton Pharmaceuticals, Inc. | -1.19 Million USD | -32742.869% |
| Lantern Pharma Inc. | -17.87 Million USD | -2089.822% |
| Inhibikase Therapeutics, Inc. | -20.08 Million USD | -1848.686% |
| Novavax, Inc. | -566.51 Million USD | 30.895% |
| Janux Therapeutics, Inc. | -72.97 Million USD | -436.438% |
| Pyxis Oncology, Inc. | -82.19 Million USD | -376.285% |
| TransCode Therapeutics, Inc. | -19.41 Million USD | -1916.05% |
| Ocuphire Pharma, Inc. | -10.56 Million USD | -3606.21% |
| Outlook Therapeutics, Inc. | -53.12 Million USD | -636.898% |
| Madrigal Pharmaceuticals, Inc. | -380.49 Million USD | -2.889% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1510.62% |
| SELLAS Life Sciences Group, Inc. | -37.86 Million USD | -933.793% |
| Syros Pharmaceuticals, Inc. | -128.98 Million USD | -203.507% |
| Barinthus Biotherapeutics plc | -83.91 Million USD | -366.534% |
| Windtree Therapeutics, Inc. | -17.53 Million USD | -2132.094% |
| Xeris Biopharma Holdings, Inc. | -44.01 Million USD | -789.541% |
| Clearside Biomedical, Inc. | -24.84 Million USD | -1475.781% |
| C4 Therapeutics, Inc. | -139.03 Million USD | -181.583% |
| Alnylam Pharmaceuticals, Inc. | -282.17 Million USD | -38.739% |
| AlloVir, Inc. | -181.33 Million USD | -115.896% |
| Arrowhead Pharmaceuticals, Inc. | -205 Million USD | -90.967% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1238.051% |
| Bicycle Therapeutics plc | -189.94 Million USD | -106.104% |
| BioXcel Therapeutics, Inc. | -171.78 Million USD | -127.898% |
| ChromaDex Corporation | -5.59 Million USD | -6892.088% |
| Chimerix, Inc. | -93.06 Million USD | -320.66% |
| Corbus Pharmaceuticals Holdings, Inc. | -45.07 Million USD | -768.479% |
| Caribou Biosciences, Inc. | -116.05 Million USD | -237.317% |
| CRISPR Therapeutics AG | -222.53 Million USD | -75.919% |
| Precision BioSciences, Inc. | -43.73 Million USD | -795.114% |
| Fate Therapeutics, Inc. | -190.51 Million USD | -105.493% |
| Fortress Biotech, Inc. | -142.34 Million USD | -175.033% |
| Fortress Biotech, Inc. | -142.34 Million USD | -175.033% |
| HOOKIPA Pharma Inc. | -97.69 Million USD | -300.728% |
| ImmuCell Corporation | -5.74 Million USD | -6710.746% |
| IDEAYA Biosciences, Inc. | -134.42 Million USD | -191.222% |
| Immix Biopharma, Inc. | -16.14 Million USD | -2325.403% |
| Incyte Corporation | 620.52 Million USD | 163.09% |
| Innoviva, Inc. | 176.7 Million USD | 321.543% |
| IO Biotech, Inc. | -91.44 Million USD | -328.121% |
| Jaguar Health, Inc. | -34.29 Million USD | -1041.661% |
| Keros Therapeutics, Inc. | -169.94 Million USD | -130.366% |
| Ligand Pharmaceuticals Incorporated | 11.94 Million USD | 3378.236% |
| ContextLogic Inc. | -328 Million USD | -19.356% |
| MiMedx Group, Inc. | 37.11 Million USD | 1154.766% |
| MEI Pharma, Inc. | 14.54 Million USD | 2792.113% |
| NextCure, Inc. | -67.63 Million USD | -478.806% |
| Onconetix, Inc. | -36.03 Million USD | -986.42% |
| Oncternal Therapeutics, Inc. | -41.71 Million USD | -838.503% |
| Opthea Limited | -191.84 Million USD | -104.067% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -14126.45% |
| Vaxcyte, Inc. | -468.04 Million USD | 16.356% |
| PDS Biotechnology Corporation | -43.04 Million USD | -809.478% |
| Precigen, Inc. | -88.92 Million USD | -340.254% |
| Pharming Group N.V. | -4.87 Million USD | -7923.024% |
| Phathom Pharmaceuticals, Inc. | -167.31 Million USD | -133.986% |
| Pieris Pharmaceuticals, Inc. | -29.75 Million USD | -1215.657% |
| PureTech Health plc | -146.19 Million USD | -167.777% |
| Rigel Pharmaceuticals, Inc. | -20.49 Million USD | -1810.531% |
| Avidity Biosciences, Inc. | -235.59 Million USD | -66.167% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.3 Million USD | -1510.62% |
| Sangamo Therapeutics, Inc. | -274 Million USD | -42.876% |
| Sol-Gel Technologies Ltd. | -29.3 Million USD | -1235.905% |
| Acelyrin, Inc. | -422.06 Million USD | 7.245% |
| Salarius Pharmaceuticals, Inc. | -12.89 Thousand USD | -3035873.801% |
| Summit Therapeutics Inc. | -89.73 Million USD | -336.265% |
| Sensei Biotherapeutics, Inc. | -37.06 Million USD | -956.246% |
| Senti Biosciences, Inc. | -92.72 Million USD | -322.193% |
| Stoke Therapeutics, Inc. | -114.77 Million USD | -241.097% |
| Elevation Oncology, Inc. | -45.44 Million USD | -761.452% |
| Alaunos Therapeutics, Inc. | -34.26 Million USD | -1042.461% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -9831.056% |
| Entrada Therapeutics, Inc. | -3.16 Million USD | -12280.993% |
| VistaGen Therapeutics, Inc. | -33.02 Million USD | -1085.57% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -4505.188% |
| Wave Life Sciences Ltd. | -67.99 Million USD | -475.75% |
| Seer, Inc. | -103.46 Million USD | -278.384% |
| Verrica Pharmaceuticals Inc. | -65.75 Million USD | -495.336% |
| Aadi Bioscience, Inc. | -71.93 Million USD | -444.238% |
| ESSA Pharma Inc. | -32.13 Million USD | -1118.291% |
| GlycoMimetics, Inc. | -39.27 Million USD | -896.777% |
| GT Biopharma, Inc. | -13.57 Million USD | -2783.67% |
| Inhibrx Biosciences, Inc. | -219.22 Million USD | -78.581% |
| Akebia Therapeutics, Inc. | -46.25 Million USD | -746.349% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 550.96% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -589.736% |
| Orchestra BioMed Holdings, Inc. | -51.5 Million USD | -660.08% |
| Alzamend Neuro, Inc. | -9.93 Million USD | -3839.434% |
| Sorrento Therapeutics, Inc. | -504.31 Million USD | 22.373% |
| TRACON Pharmaceuticals, Inc. | -6.89 Million USD | -5575.37% |
| Viracta Therapeutics, Inc. | -50.69 Million USD | -672.27% |
| Rocket Pharmaceuticals, Inc. | -259.65 Million USD | -50.77% |
| Aptose Biosciences Inc. | -52.35 Million USD | -647.74% |
| ZyVersa Therapeutics, Inc. | -14.42 Million USD | -2614.743% |
| Soligenix, Inc. | -7.69 Million USD | -4985.607% |
| Century Therapeutics, Inc. | -146.54 Million USD | -167.143% |
| Kura Oncology, Inc. | -165.8 Million USD | -136.114% |
| TScan Therapeutics, Inc. | -93.45 Million USD | -318.891% |
| Intensity Therapeutics, Inc. | -8.31 Million USD | -4605.938% |
| Ocean Biomedical, Inc. | -2.48 Million USD | -15675.34% |
| CytomX Therapeutics, Inc. | -6.48 Million USD | -5937.739% |
| Autolus Therapeutics plc | -195.02 Million USD | -100.734% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -362.439% |
| EyePoint Pharmaceuticals, Inc. | -73.66 Million USD | -431.464% |
| Eterna Therapeutics Inc. | -21.13 Million USD | -1752.316% |
| Adaptive Biotechnologies Corporation | -227.03 Million USD | -72.435% |
| GRI Bio, Inc. | -11.38 Million USD | -3338.017% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8569.436% |
| Tenaya Therapeutics, Inc. | -131.19 Million USD | -198.405% |
| IGM Biosciences, Inc. | -263.46 Million USD | -48.594% |
| INmune Bio, Inc. | -29.74 Million USD | -1216.321% |
| Heron Therapeutics, Inc. | -110.61 Million USD | -253.919% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -928.191% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2349.954% |
| Entero Therapeutics, Inc. | -15.77 Million USD | -2382.349% |
| Milestone Pharmaceuticals Inc. | -61.09 Million USD | -540.753% |
| X4 Pharmaceuticals, Inc. | -107.52 Million USD | -264.099% |
| Atara Biotherapeutics, Inc. | -276 Million USD | -41.84% |
| Coherus BioSciences, Inc. | -203.19 Million USD | -92.662% |
| Verastem, Inc. | -92.08 Million USD | -325.141% |
| Abeona Therapeutics Inc. | -47.13 Million USD | -730.565% |
| Pliant Therapeutics, Inc. | -184.14 Million USD | -112.597% |
| Tonix Pharmaceuticals Holding Corp. | -118.38 Million USD | -230.704% |
| Histogen Inc. | -10.64 Million USD | -3578.352% |
| Aprea Therapeutics, Inc. | -15.47 Million USD | -2430.3% |
| Surrozen, Inc. | -45.78 Million USD | -755.149% |
| Organovo Holdings, Inc. | -15.08 Million USD | -2495.035% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7590.94% |
| Ovid Therapeutics Inc. | -59.28 Million USD | -560.387% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -663.222% |
| CASI Pharmaceuticals, Inc. | -25.28 Million USD | -1448.604% |
| Cadrenal Therapeutics, Inc. Common Stock | -7.63 Million USD | -5028.98% |
| Centessa Pharmaceuticals plc | -171.28 Million USD | -128.562% |
| Hepion Pharmaceuticals, Inc. | -48.44 Million USD | -708.057% |
| Arcturus Therapeutics Holdings Inc. | -78.2 Million USD | -400.591% |
| BioRestorative Therapies, Inc. | -15.22 Million USD | -2472.057% |
| Apollomics, Inc. | -54.83 Million USD | -613.949% |
| Amarin Corporation plc | -67.58 Million USD | -479.226% |
| Mesoblast Limited | -58.79 Million USD | -565.862% |
| Turnstone Biologics Corp. | -59.03 Million USD | -563.178% |
| Kymera Therapeutics, Inc. | -165.53 Million USD | -136.505% |
| Synaptogenix, Inc. | -8.31 Million USD | -4608.851% |
| Tiziana Life Sciences Ltd | -14.58 Million USD | -2583.991% |
| Aurinia Pharmaceuticals Inc. | -91.69 Million USD | -326.963% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -8070.506% |
| Monopar Therapeutics Inc. | -8.83 Million USD | -4332.981% |
| Exelixis, Inc. | 170.88 Million USD | 329.094% |
| Better Therapeutics, Inc. | -38.26 Million USD | -923.174% |
| Nurix Therapeutics, Inc. | -155.06 Million USD | -152.47% |
| Apellis Pharmaceuticals, Inc. | -517.12 Million USD | 24.295% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3215.702% |
| Dermata Therapeutics, Inc. | -8.04 Million USD | -4768.087% |
| Aridis Pharmaceuticals, Inc. | -29.99 Million USD | -1205.261% |
| Gritstone bio, Inc. | -154.63 Million USD | -153.17% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -468.518% |
| TNF Pharmaceuticals, Inc. | -17.12 Million USD | -2186.316% |
| Avid Bioservices, Inc. | -18.67 Million USD | -1995.979% |
| Insmed Incorporated | -709.62 Million USD | 44.832% |
| Virpax Pharmaceuticals, Inc. | -15.68 Million USD | -2395.171% |
| MediWound Ltd. | -15.29 Million USD | -2460.412% |
| OmniAb, Inc. | -69.41 Million USD | -463.948% |
| Alector, Inc. | -151.74 Million USD | -157.999% |
| Seres Therapeutics, Inc. | -107.98 Million USD | -262.545% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -650.723% |
| Zai Lab Limited | -366.57 Million USD | -6.796% |
| Revance Therapeutics, Inc. | -316.77 Million USD | -23.584% |
| Aura Biosciences, Inc. | -84.99 Million USD | -360.622% |
| Lyell Immunopharma, Inc. | -245.49 Million USD | -59.466% |
| Immunic, Inc. | -99.22 Million USD | -294.553% |
| Tarsus Pharmaceuticals, Inc. | -143.15 Million USD | -173.465% |
| Veracyte, Inc. | -85.79 Million USD | -356.305% |
| InMed Pharmaceuticals Inc. | - USD | Infinity% |
| FibroGen, Inc. | -281.81 Million USD | -38.916% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2655.011% |
| Adial Pharmaceuticals, Inc. | -6.88 Million USD | -5583.653% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.79 Million USD | -1983.196% |
| Jazz Pharmaceuticals plc | 578.58 Million USD | 167.663% |
| Cyclacel Pharmaceuticals, Inc. | -25.45 Million USD | -1438.078% |
| Amylyx Pharmaceuticals, Inc. | 38.8 Million USD | 1108.935% |
| TG Therapeutics, Inc. | 20.63 Million USD | 1997.383% |
| Galecto, Inc. | -39.9 Million USD | -881.047% |
| Calithera Biosciences, Inc. | -42.07 Million USD | -830.473% |
| Fortrea Holdings Inc. | 63.1 Million USD | 720.423% |
| KalVista Pharmaceuticals, Inc. | -140.44 Million USD | -178.748% |
| Aptevo Therapeutics Inc. | -28.87 Million USD | -1255.658% |
| XBiotech Inc. | -37.51 Million USD | -943.687% |
| Jasper Therapeutics, Inc. | -68.86 Million USD | -468.518% |
| Lyra Therapeutics, Inc. | -67.12 Million USD | -483.264% |
| Foghorn Therapeutics Inc. | -107.9 Million USD | -262.804% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1424.957% |
| Theravance Biopharma, Inc. | -53.29 Million USD | -634.607% |
| Ultragenyx Pharmaceutical Inc. | -569.2 Million USD | 31.223% |
| Metagenomi, Inc. Common Stock | -78.49 Million USD | -398.76% |
| Vaxxinity, Inc. | -58.28 Million USD | -571.677% |
| BioCryst Pharmaceuticals, Inc. | -103.7 Million USD | -277.486% |
| Gain Therapeutics, Inc. | -22.25 Million USD | -1659.244% |
| Cartesian Therapeutics, Inc. | -86.41 Million USD | -353.026% |
| NexImmune, Inc. | -29.19 Million USD | -1241.054% |
| Creative Medical Technology Holdings, Inc. | -5.62 Million USD | -6865.797% |
| Marker Therapeutics, Inc. | -14.58 Million USD | -2584.842% |
| Regeneron Pharmaceuticals, Inc. | 4.04 Billion USD | 109.673% |
| Chemomab Therapeutics Ltd. | -25.45 Million USD | -1437.716% |
| Scopus BioPharma Inc. | -11.71 Million USD | -3241.794% |
| RAPT Therapeutics, Inc. | -127.06 Million USD | -208.107% |
| Ainos, Inc. | -13.2 Million USD | -2864.374% |
| Pluri Inc. | -22.15 Million USD | -1666.798% |
| Prothena Corporation plc | -191.03 Million USD | -104.928% |
| Adaptimmune Therapeutics plc | -138.03 Million USD | -183.608% |
| Celularity Inc. | -192.28 Million USD | -103.595% |
| Rallybio Corporation | -78.93 Million USD | -395.98% |
| Cue Biopharma, Inc. | -52.14 Million USD | -650.709% |
| MeiraGTx Holdings plc | -137.06 Million USD | -185.63% |
| Omeros Corporation | -164.53 Million USD | -137.943% |
| Humacyte, Inc. | -100.04 Million USD | -291.303% |
| Immunocore Holdings plc | -59.64 Million USD | -556.318% |
| Cocrystal Pharma, Inc. | -18.55 Million USD | -2009.419% |
| Cidara Therapeutics, Inc. | -24.48 Million USD | -1499.016% |
| Blueprint Medicines Corporation | -486.27 Million USD | 19.493% |
| CalciMedica, Inc. | -21.87 Million USD | -1689.655% |
| Cabaletta Bio, Inc. | -74.66 Million USD | -424.36% |
| Marinus Pharmaceuticals, Inc. | -131.48 Million USD | -197.743% |
| Scholar Rock Holding Corporation | -171.29 Million USD | -128.545% |
| Sana Biotechnology, Inc. | -326.9 Million USD | -19.757% |
| Pulmatrix, Inc. | -14.74 Million USD | -2555.95% |
| Elicio Therapeutics, Inc. | -35.74 Million USD | -995.222% |
| Vigil Neuroscience, Inc. | -88.86 Million USD | -340.536% |
| Intellia Therapeutics, Inc. | -515.29 Million USD | 24.026% |
| Adlai Nortye Ltd. American Depositary Shares | -67.55 Million USD | -479.543% |
| Cytokinetics, Incorporated | -496.2 Million USD | 21.104% |
| Eloxx Pharmaceuticals, Inc. | -34.41 Million USD | -1037.415% |
| Nutriband Inc. | -4.87 Million USD | -7935.57% |
| Protara Therapeutics, Inc. | -43.61 Million USD | -797.638% |
| Vor Biopharma Inc. | -126.03 Million USD | -210.615% |
| Roivant Sciences Ltd. | 4.24 Billion USD | 109.229% |
| Evogene Ltd. | -26.39 Million USD | -1383.411% |
| ProKidney Corp. | -151.52 Million USD | -158.37% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -506.627% |
| Hoth Therapeutics, Inc. | -7.69 Million USD | -4989.374% |
| BridgeBio Pharma, Inc. | -607.37 Million USD | 35.544% |
| CorMedix Inc. | -48.95 Million USD | -699.642% |
| BioLineRx Ltd. | -49.69 Million USD | -687.795% |
| Tango Therapeutics, Inc. | -114.17 Million USD | -242.889% |
| Galectin Therapeutics Inc. | -38.07 Million USD | -928.281% |
| Atai Life Sciences N.V. | -125.47 Million USD | -212.014% |
| Renovaro Biosciences Inc. | -81.63 Million USD | -379.533% |
| Aerovate Therapeutics, Inc. | -81.4 Million USD | -380.889% |
| Zentalis Pharmaceuticals, Inc. | -248.98 Million USD | -57.231% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1173.543% |
| MediciNova, Inc. | -9.9 Million USD | -3854.308% |
| Praxis Precision Medicines, Inc. | -126.37 Million USD | -209.787% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5305.443% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1363.889% |
| Axsome Therapeutics, Inc. | -231.82 Million USD | -68.872% |
| Biomea Fusion, Inc. | -126.13 Million USD | -210.371% |
| PTC Therapeutics, Inc. | -349.4 Million USD | -12.045% |
| Mereo BioPharma Group plc | -28.41 Million USD | -1277.699% |
| Cullinan Oncology, Inc. | -191.08 Million USD | -104.872% |
| Syndax Pharmaceuticals, Inc. | -229.95 Million USD | -70.246% |
| Absci Corporation | -115.51 Million USD | -238.906% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1319.1% |
| 4D Molecular Therapeutics, Inc. | -112.86 Million USD | -246.857% |
| Dyne Therapeutics, Inc. | -242.16 Million USD | -61.663% |
| Kiniksa Pharmaceuticals, Ltd. | -25.19 Million USD | -1453.766% |
| Ventyx Biosciences, Inc. | -207.99 Million USD | -88.22% |
| Allakos Inc. | -196.05 Million USD | -99.681% |
| Imunon, Inc. | -21.03 Million USD | -1761.526% |
| Fulcrum Therapeutics, Inc. | -110.66 Million USD | -253.762% |
| Corcept Therapeutics Incorporated | 107.28 Million USD | 464.914% |
| BioAtla, Inc. | -129.68 Million USD | -201.871% |
| NLS Pharmaceutics AG | -11.8 Million USD | -3215.702% |
| Bio-Path Holdings, Inc. | -15.84 Million USD | -2371.041% |
| Allogene Therapeutics, Inc. | -327.73 Million USD | -19.452% |
| Larimar Therapeutics, Inc. | -41.75 Million USD | -837.514% |
| XOMA Corporation | -41.84 Million USD | -835.498% |
| Kezar Life Sciences, Inc. | -105.23 Million USD | -272.005% |
| Cara Therapeutics, Inc. | -121.49 Million USD | -222.225% |
| aTyr Pharma, Inc. | -54.91 Million USD | -612.844% |
| Aligos Therapeutics, Inc. | -87.42 Million USD | -347.787% |
| Akero Therapeutics, Inc. | -172.87 Million USD | -126.463% |
| Viridian Therapeutics, Inc. | -254.45 Million USD | -53.856% |
| Eliem Therapeutics, Inc. | -21.46 Million USD | -1723.754% |
| EyeGate Pharmaceuticals, Inc. | -8.21 Million USD | -4666.817% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2229.448% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4426968.55% |
| Halozyme Therapeutics, Inc. | 337.57 Million USD | 215.971% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5891.516% |
| UroGen Pharma Ltd. | -65.53 Million USD | -497.362% |
| Sutro Biopharma, Inc. | -89.27 Million USD | -338.503% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -5290.147% |
| Orgenesis Inc. | -53.63 Million USD | -629.896% |
| Entera Bio Ltd. | -8.89 Million USD | -4303.183% |
| GH Research PLC | -41.22 Million USD | -849.704% |
| Lisata Therapeutics, Inc. | -25.7 Million USD | -1422.822% |
| Reneo Pharmaceuticals, Inc. | -83.05 Million USD | -371.37% |
| Xencor, Inc. | -138.63 Million USD | -182.379% |
| 60 Degrees Pharmaceuticals, Inc. | -5.15 Million USD | -7494.931% |
| Replimune Group, Inc. | -234.77 Million USD | -66.751% |
| Coeptis Therapeutics Holdings, Inc. | -21.49 Million USD | -1721.622% |
| Vanda Pharmaceuticals Inc. | -13.95 Million USD | -2705.956% |
| Lexaria Bioscience Corp. | -6.53 Million USD | -5891.516% |
| Portage Biotech Inc. | -18.25 Million USD | -2044.782% |
| Cardio Diagnostics Holdings, Inc. | -7.24 Million USD | -5305.443% |
| Olema Pharmaceuticals, Inc. | -104.96 Million USD | -272.983% |
| OncoCyte Corporation | -25.13 Million USD | -1457.475% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3362.998% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3316.993% |
| Purple Biotech Ltd. | 22.27 Million USD | 1857.833% |
| CollPlant Biotechnologies Ltd. | -7.51 Million USD | -5111.488% |
| scPharmaceuticals Inc. | -55.39 Million USD | -606.706% |
| ProMIS Neurosciences, Inc. | -18.89 Million USD | -1971.613% |
| HilleVax, Inc. | -133.34 Million USD | -193.59% |
| NeuroSense Therapeutics Ltd. | -12.04 Million USD | -3149.124% |
| Tharimmune, Inc. | -9.45 Million USD | -4040.432% |
| Genprex, Inc. | -31.07 Million USD | -1159.79% |
| Neumora Therapeutics, Inc. Common Stock | -188.19 Million USD | -108.023% |
| Atossa Therapeutics, Inc. | -31.37 Million USD | -1147.688% |
| XTL Biopharmaceuticals Ltd. | -765 Thousand USD | -51074.771% |
| Virios Therapeutics, Inc. | -5.44 Million USD | -7087.311% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2485574.358% |
| Savara Inc. | -60 Million USD | -552.402% |
| Curis, Inc. | -48.33 Million USD | -709.995% |
| Daré Bioscience, Inc. | -30.83 Million USD | -1169.418% |
| Carmell Therapeutics Corporation | -5.21 Million USD | -7403.661% |
| Titan Pharmaceuticals, Inc. | -7.27 Million USD | -5279.786% |
| Achieve Life Sciences, Inc. | -27.25 Million USD | -1336.65% |
| BeiGene, Ltd. | -1.2 Billion USD | 67.585% |
| Kiromic BioPharma, Inc. | -19.93 Million USD | -1863.394% |
| Revolution Medicines, Inc. Warrant | -487.18 Million USD | 19.643% |
| Protagonist Therapeutics, Inc. | -93.65 Million USD | -318.023% |
| Erasca, Inc. | -141.52 Million USD | -176.62% |
| bluebird bio, Inc. | -244.26 Million USD | -60.273% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8547.874% |
| BioMarin Pharmaceutical Inc. | 194.44 Million USD | 301.34% |
| DBV Technologies S.A. | -76.43 Million USD | -412.203% |
| Protagenic Therapeutics, Inc. | -4.52 Million USD | -8547.874% |
| Moderna, Inc. | -4.23 Billion USD | 90.765% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -818.789% |
| Fresh Tracks Therapeutics, Inc. | -6.36 Million USD | -6055.456% |
| Molecular Templates, Inc. | -10.46 Million USD | -3640.56% |
| Acrivon Therapeutics, Inc. Common Stock | -67.23 Million USD | -482.249% |
| Travere Therapeutics, Inc. | -376.74 Million USD | -3.913% |
| Monte Rosa Therapeutics, Inc. | -143.31 Million USD | -173.173% |
| Spruce Biosciences, Inc. | -51.99 Million USD | -652.961% |
| Celldex Therapeutics, Inc. | -154.54 Million USD | -153.321% |
| Cogent Biosciences, Inc. | -208.13 Million USD | -88.097% |
| MacroGenics, Inc. | -168.24 Million USD | -132.69% |
| RenovoRx, Inc. | -11.39 Million USD | -3335.302% |
| Adicet Bio, Inc. | -152.03 Million USD | -157.493% |
| Prime Medicine, Inc. | -191.29 Million USD | -104.654% |
| Aditxt, Inc. | -26.06 Million USD | -1402.113% |
| Adagene Inc. | -23.71 Million USD | -1550.46% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5255.428% |
| Quantum-Si incorporated | -111.17 Million USD | -252.148% |
| Maravai LifeSciences Holdings, Inc. | -31.64 Million USD | -1137.004% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -2585.507% |
| Voyager Therapeutics, Inc. | 122.01 Million USD | 420.854% |
| SciSparc Ltd. | -5.77 Million USD | -6681.344% |
| Vericel Corporation | -6.46 Million USD | -5956.42% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4422.377% |
| Minerva Neurosciences, Inc. | -23.11 Million USD | -1593.314% |
| Generation Bio Co. | -138.56 Million USD | -182.534% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -371.501% |
| Black Diamond Therapeutics, Inc. | -86.46 Million USD | -352.796% |
| Arcutis Biotherapeutics, Inc. | -241.1 Million USD | -62.375% |
| Invivyd, Inc. | -207.78 Million USD | -88.411% |
| Relay Therapeutics, Inc. | -373 Million USD | -4.956% |
| Quoin Pharmaceuticals, Ltd. | -9.37 Million USD | -4074.301% |
| Spero Therapeutics, Inc. | 21.48 Million USD | 1922.48% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3705.648% |
| 2seventy bio, Inc. | -216.7 Million USD | -80.656% |
| ADMA Biologics, Inc. | 21.63 Million USD | 1909.759% |
| Clene Inc. | -40.54 Million USD | -865.681% |
| Capricor Therapeutics, Inc. | -24.07 Million USD | -1525.921% |
| Boundless Bio, Inc. Common Stock | -54.79 Million USD | -614.444% |
| GeoVax Labs, Inc. | -26.74 Million USD | -1363.889% |
| Recursion Pharmaceuticals, Inc. | -350.06 Million USD | -11.834% |
| Citius Pharmaceuticals, Inc. | -36.73 Million USD | -965.792% |
| Contineum Therapeutics, Inc. Class A Common Stock | 16.07 Million USD | 2535.075% |
| Relmada Therapeutics, Inc. | -103.7 Million USD | -277.512% |
| Finch Therapeutics Group, Inc. | -34 Million USD | -1051.365% |
| ALX Oncology Holdings Inc. | -170.27 Million USD | -129.91% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 42.791% |
| Evaxion Biotech A/S | -22.19 Million USD | -1663.693% |
| Ocular Therapeutix, Inc. | -82.38 Million USD | -375.209% |
| Verve Therapeutics, Inc. | -223.12 Million USD | -75.457% |
| Trevena, Inc. | -35.28 Million USD | -1009.405% |
| Surrozen, Inc. | -45.78 Million USD | -755.149% |
| Tyra Biosciences, Inc. | -79.94 Million USD | -389.695% |
| Cingulate Inc. | -22.75 Million USD | -1620.127% |
| Galmed Pharmaceuticals Ltd. | 7.49 Million USD | 5325.4% |
| Unity Biotechnology, Inc. | -44.66 Million USD | -776.457% |
| Tenax Therapeutics, Inc. | -8.23 Million USD | -4654.552% |
| Terns Pharmaceuticals, Inc. | -102.55 Million USD | -281.723% |
| ACADIA Pharmaceuticals Inc. | -73.37 Million USD | -433.514% |
| Connect Biopharma Holdings Limited | -62.07 Million USD | -530.678% |
| Clearmind Medicine Inc. | -8.74 Million USD | -4378.564% |
| Kronos Bio, Inc. | -121.83 Million USD | -221.339% |
| Bolt Biotherapeutics, Inc. | -76.19 Million USD | -413.789% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -13247.733% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -288.276% |
| Statera Biopharma, Inc. | -98.34 Million USD | -298.08% |
| ImmunityBio, Inc. | -362.25 Million USD | -8.071% |
| Korro Bio, Inc. | -84.53 Million USD | -363.112% |
| Kineta, Inc. | -15.72 Million USD | -2389.9% |
| BioVie Inc. | -32.17 Million USD | -1116.569% |
| Codexis, Inc. | -68.06 Million USD | -475.133% |
| Celularity Inc. | -192.28 Million USD | -103.595% |
| Crinetics Pharmaceuticals, Inc. | -222.6 Million USD | -75.864% |
| Celcuity Inc. | -66.23 Million USD | -491.099% |
| Virax Biolabs Group Limited | -6.49 Million USD | -5926.147% |
| Cibus, Inc. | -318.88 Million USD | -22.768% |
| Eledon Pharmaceuticals, Inc. | -43 Million USD | -810.435% |
| eFFECTOR Therapeutics, Inc. | -33.84 Million USD | -1056.74% |
| IN8bio, Inc. | -30.33 Million USD | -1190.46% |
| Kodiak Sciences Inc. | -277.32 Million USD | -41.167% |
| Annexon, Inc. | -143.72 Million USD | -172.39% |
| Adverum Biotechnologies, Inc. | -123.79 Million USD | -216.248% |
| Assembly Biosciences, Inc. | -64.64 Million USD | -505.586% |
| Avalo Therapeutics, Inc. | -23.44 Million USD | -1569.881% |
| Ionis Pharmaceuticals, Inc. | -353.73 Million USD | -10.674% |
| Eyenovia, Inc. | -25.4 Million USD | -1440.896% |
| Puma Biotechnology, Inc. | 32.64 Million USD | 1299.409% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6938.601% |
| Xilio Therapeutics, Inc. | -79.13 Million USD | -394.72% |
| Arcellx, Inc. | -89.88 Million USD | -335.566% |
| Cardiff Oncology, Inc. | -45.41 Million USD | -762.078% |
| Enanta Pharmaceuticals, Inc. | -137.2 Million USD | -185.326% |
| Regulus Therapeutics Inc. | -31.1 Million USD | -1158.436% |
| Moolec Science SA | -6.65 Million USD | -5783.656% |
| Acumen Pharmaceuticals, Inc. | -61.13 Million USD | -540.333% |
| Geron Corporation | -193.94 Million USD | -101.856% |
| LAVA Therapeutics N.V. | -43.25 Million USD | -805.109% |
| Royalty Pharma plc | 1.49 Billion USD | 126.236% |
| Atea Pharmaceuticals, Inc. | -164.16 Million USD | -138.476% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -4096.962% |
| TFF Pharmaceuticals, Inc. | -21.89 Million USD | -1688.048% |
| Mersana Therapeutics, Inc. | -170.95 Million USD | -128.997% |
| Humacyte, Inc. | -100.04 Million USD | -291.303% |
| Structure Therapeutics Inc. | -102.77 Million USD | -280.917% |
| 89bio, Inc. | -151.2 Million USD | -158.913% |
| PMV Pharmaceuticals, Inc. | -80.13 Million USD | -388.553% |
| Avenue Therapeutics, Inc. | -14.54 Million USD | -2592.483% |
| Genelux Corporation | -24.16 Million USD | -1520.058% |
| Trevi Therapeutics, Inc. | -33.92 Million USD | -1054.046% |
| Lexicon Pharmaceuticals, Inc. | -171.75 Million USD | -127.94% |
| Notable Labs, Ltd. | -14.65 Million USD | -2570.99% |
| Liquidia Corporation | -73.38 Million USD | -433.477% |
| Mustang Bio, Inc. | -50.72 Million USD | -671.768% |
| Immunovant, Inc. | -282.7 Million USD | -38.477% |
| Quantum-Si incorporated | -111.17 Million USD | -252.148% |
| Arbutus Biopharma Corporation | -78.1 Million USD | -401.245% |
| DiaMedica Therapeutics Inc. | -21.26 Million USD | -1740.819% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -283.766% |
| Acasti Pharma Inc. | -11.31 Million USD | -3360.812% |
| MiNK Therapeutics, Inc. | -22.92 Million USD | -1607.976% |
| Pasithea Therapeutics Corp. | -15.97 Million USD | -2349.954% |
| Xenon Pharmaceuticals Inc. | -214.05 Million USD | -82.892% |
| Elevai Labs, Inc. Common Stock | -3.66 Million USD | -10569.919% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2364.352% |
| Tempest Therapeutics, Inc. | -29.15 Million USD | -1242.686% |
| Soleno Therapeutics, Inc. | -41.38 Million USD | -845.986% |
| PepGen Inc. | -84.76 Million USD | -361.844% |
| Moleculin Biotech, Inc. | -29.63 Million USD | -1221.208% |
| United Therapeutics Corporation | 1.18 Billion USD | 133.04% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1609.774% |
| Solid Biosciences Inc. | -104.31 Million USD | -275.293% |
| BriaCell Therapeutics Corp. | -32.8 Million USD | -1093.263% |
| Immuneering Corporation | -58.41 Million USD | -570.207% |
| Lixte Biotechnology Holdings, Inc. | -5.09 Million USD | -7590.94% |
| Silo Pharma, Inc. | -3.85 Million USD | -10053.746% |
| Belite Bio, Inc | -31.66 Million USD | -1136.223% |
| XOMA Corporation | -41.84 Million USD | -835.498% |
| ARS Pharmaceuticals, Inc. | -67.52 Million USD | -479.809% |
| Bionomics Limited | -17.89 Billion USD | 97.812% |
| Apogee Therapeutics, Inc. | -93 Million USD | -320.94% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1197.217% |
| uniQure N.V. | -282.87 Million USD | -38.398% |
| Cassava Sciences, Inc. | -105.95 Million USD | -269.477% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -5255.428% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -202.297% |
| Forte Biosciences, Inc. | -32.48 Million USD | -1105.095% |
| Anebulo Pharmaceuticals, Inc. | -8.3 Million USD | -4611.741% |
| Enlivex Therapeutics Ltd. | -29.39 Million USD | -1231.815% |
| Conduit Pharmaceuticals Inc. | -5.56 Million USD | -6938.601% |
| SeaStar Medical Holding Corporation | -14.21 Million USD | -2655.011% |
| FibroBiologics, Inc. Common Stock | -8.88 Million USD | -4304.174% |
| Altimmune, Inc. | -95.92 Million USD | -308.101% |
| Amicus Therapeutics, Inc. | -73.49 Million USD | -432.679% |
| Alpha Tau Medical Ltd. | 35.68 Million USD | 1197.217% |
| Compugen Ltd. | -12.99 Million USD | -2913.293% |
| Peak Bio, Inc. | -1356.23 USD | -28865726.593% |
| Zevra Therapeutics, Inc. | -49.6 Million USD | -689.225% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1640.716% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -61.569% |
| NKGen Biotech, Inc. Common Stock | -29.74 Million USD | -1216.1% |
| Zura Bio Limited | -62.63 Million USD | -524.999% |
| PolyPid Ltd. | -22.86 Million USD | -1612.017% |
| Aileron Therapeutics, Inc. | -16.27 Million USD | -2305.302% |
| NKGen Biotech, Inc. Warrants | -29.74 Million USD | -1216.1% |
| Instil Bio, Inc. | -159.16 Million USD | -145.957% |
| argenx SE | -425.04 Million USD | 7.896% |
| Immunome, Inc. | -109.53 Million USD | -257.424% |
| Compass Therapeutics, Inc. | -50.36 Million USD | -677.331% |
| Verona Pharma plc | -67.83 Million USD | -477.151% |
| enGene Holdings Inc. Warrants | -26.06 Million USD | -1402.252% |
| Shattuck Labs, Inc. | -91.95 Million USD | -325.728% |
| CervoMed Inc. | -7.81 Million USD | -4910.78% |
| LENZ Therapeutics, Inc. | -73.11 Million USD | -435.477% |
| Plus Therapeutics, Inc. | -13.32 Million USD | -2838.871% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -712.652% |
| Moolec Science SA | -6.65 Million USD | -5783.656% |
| Enveric Biosciences, Inc. | -16.44 Million USD | -2280.086% |
| Inovio Pharmaceuticals, Inc. | -135.22 Million USD | -189.504% |
| AnaptysBio, Inc. | -164.41 Million USD | -138.115% |
| Design Therapeutics, Inc. | -78.19 Million USD | -400.687% |
| Leap Therapeutics, Inc. | -87.04 Million USD | -349.773% |
| NeurAxis, Inc. | -6.66 Million USD | -5774.219% |
| Seelos Therapeutics, Inc. | -40.49 Million USD | -866.658% |
| Lumos Pharma, Inc. | -36.61 Million USD | -969.228% |
| Achilles Therapeutics plc | -75.25 Million USD | -420.214% |
| enGene Holdings Inc. Common Stock | -26.06 Million USD | -1402.252% |
| 180 Life Sciences Corp. | -13.47 Million USD | -2804.745% |
| Opiant Pharmaceuticals, Inc. | 5.15 Million USD | 7692.385% |
| CERo Therapeutics Holdings, Inc. | -2.93 Million USD | -13247.733% |
| Nutriband Inc. | -4.87 Million USD | -7935.57% |
| ORIC Pharmaceuticals, Inc. | -110.78 Million USD | -253.391% |
| CG Oncology, Inc. Common stock | -55.44 Million USD | -606.031% |
| Fractyl Health, Inc. Common Stock | -50.83 Million USD | -670.098% |
| Rani Therapeutics Holdings, Inc. | -66.09 Million USD | -492.274% |
| MoonLake Immunotherapeutics | -54.12 Million USD | -623.327% |
| Palisade Bio, Inc. | -13.07 Million USD | -2895.31% |
| Tourmaline Bio, Inc. | -45.4 Million USD | -762.135% |
| Beam Therapeutics Inc. | -176.48 Million USD | -121.825% |
| Neurogene Inc. | -55.58 Million USD | -604.329% |
| Mirum Pharmaceuticals, Inc. | -109.15 Million USD | -258.656% |
| AEON Biopharma, Inc. | -48.42 Million USD | -708.373% |
| CARGO Therapeutics, Inc. Common Stock | -96.71 Million USD | -304.805% |
| Sesen Bio, Inc. | -25.9 Million USD | -1411.008% |
| Enliven Therapeutics, Inc. | -83.52 Million USD | -368.684% |
| Kiora Pharmaceuticals, Inc. | -12.58 Million USD | -3010.274% |
| Iovance Biotherapeutics, Inc. | -460.55 Million USD | 14.997% |
| Taysha Gene Therapies, Inc. | -72.43 Million USD | -440.437% |
| Athira Pharma, Inc. | -125.46 Million USD | -212.026% |
| Vaccinex, Inc. | -22.88 Million USD | -1610.671% |
| HCW Biologics Inc. | -25.71 Million USD | -1422.279% |
| XOMA Corporation | -41.84 Million USD | -835.498% |
| Nektar Therapeutics | -137.42 Million USD | -184.873% |
| Arvinas, Inc. | -401.5 Million USD | 2.494% |
| Tevogen Bio Holdings Inc. | -8843.03 USD | -4426968.55% |
| Merus N.V. | -156.54 Million USD | -150.076% |
| Omega Therapeutics, Inc. | -100.26 Million USD | -290.468% |
| Quince Therapeutics, Inc. | -34.62 Million USD | -1030.812% |
| Rezolute, Inc. | -70.42 Million USD | -455.908% |
| Clene Inc. | -40.54 Million USD | -865.681% |
| Indaptus Therapeutics, Inc. | -16.37 Million USD | -2290.253% |
| BeyondSpring Inc. | -23.11 Million USD | -1593.722% |
| Synlogic, Inc. | -55.16 Million USD | -609.717% |
| Allarity Therapeutics, Inc. | -17.92 Million USD | -2083.541% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -3516.842% |
| Peak Bio, Inc. | -1356.23 USD | -28865726.593% |
| Werewolf Therapeutics, Inc. | -40.5 Million USD | -866.563% |
| Krystal Biotech, Inc. | -109.72 Million USD | -256.783% |
| Karyopharm Therapeutics Inc. | -129.53 Million USD | -202.213% |
| SpringWorks Therapeutics, Inc. | -343.01 Million USD | -14.132% |
| Lipella Pharmaceuticals Inc. | -4.74 Million USD | -8148.86% |
| MannKind Corporation | 8.67 Million USD | 4611.258% |
| Ikena Oncology, Inc. | -75.41 Million USD | -419.096% |
| Cyclerion Therapeutics, Inc. | -9.64 Million USD | -3958.122% |
| Gyre Therapeutics, Inc. | -67.23 Million USD | -482.31% |
| Gossamer Bio, Inc. | -183.75 Million USD | -113.044% |
| CohBar, Inc. | -12.38 Million USD | -3060.136% |
| Cognition Therapeutics, Inc. | -50.72 Million USD | -671.798% |
| NRx Pharmaceuticals, Inc. | -27.58 Million USD | -1319.1% |
| Legend Biotech Corporation | -439.48 Million USD | 10.921% |
| Mural Oncology plc | -194.63 Million USD | -101.136% |
| Biora Therapeutics, Inc. | -67.14 Million USD | -483.065% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -2324.778% |
| Disc Medicine, Inc. | -91.12 Million USD | -329.615% |
| Champions Oncology, Inc. | -7.35 Million USD | -5222.009% |
| REGENXBIO Inc. | -268.12 Million USD | -46.008% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3552.549% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -602.143% |
| Cellectar Biosciences, Inc. | -38.96 Million USD | -904.827% |
| Edgewise Therapeutics, Inc. | -114.35 Million USD | -242.338% |
| Vaxart, Inc. | -83.34 Million USD | -369.707% |
| PharmaCyte Biotech, Inc. | -8.52 Million USD | -4494.914% |
| Aldeyra Therapeutics, Inc. | -42.79 Million USD | -814.816% |
| Cellectis S.A. | -106.62 Million USD | -267.159% |
| Longeveron Inc. | -21.02 Million USD | -1761.653% |
| Repare Therapeutics Inc. | -116.22 Million USD | -236.838% |
| Sarepta Therapeutics, Inc. | -267.82 Million USD | -46.173% |
| Inozyme Pharma, Inc. | -75.64 Million USD | -417.532% |
| Revolution Medicines, Inc. | -487.18 Million USD | 19.643% |
| Nymox Pharmaceutical Corporation | -6.65 Million USD | -5785.253% |
| Third Harmonic Bio, Inc. | -43.95 Million USD | -790.674% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -424.852% |
| AN2 Therapeutics, Inc. | -69.63 Million USD | -462.199% |
| Anixa Biosciences, Inc. | -11.01 Million USD | -3455.417% |
| Vertex Pharmaceuticals Incorporated | 4.3 Billion USD | 109.088% |
| Denali Therapeutics Inc. | -196.69 Million USD | -99.028% |
| Revelation Biosciences, Inc. | -8.65 Million USD | -4422.377% |
| Veru Inc. | -93.78 Million USD | -317.443% |
| Corvus Pharmaceuticals, Inc. | -23.32 Million USD | -1578.113% |
| Cingulate Inc. | -22.75 Million USD | -1620.127% |
| Passage Bio, Inc. | -108.38 Million USD | -261.187% |
| Context Therapeutics Inc. | -25.07 Million USD | -1461.413% |
| Exicure, Inc. | -14.99 Million USD | -2510.609% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -89.983% |
| Oramed Pharmaceuticals Inc. | -40.59 Million USD | -864.301% |
| Scinai Immunotherapeutics Ltd. | -9.71 Million USD | -3928.914% |
| Rhythm Pharmaceuticals, Inc. | -184.35 Million USD | -112.353% |
| Nuvalent, Inc. | -149.49 Million USD | -161.878% |
| ABVC BioPharma, Inc. | -8.21 Million USD | -4664.639% |
| Carisma Therapeutics, Inc. | -88.73 Million USD | -341.207% |
| Unicycive Therapeutics, Inc. | -20.77 Million USD | -1784.505% |
| OmniAb, Inc. | -69.41 Million USD | -463.948% |
| Anew Medical, Inc. | -1.3 Million USD | -29994.939% |
| Fennec Pharmaceuticals Inc. | -12.77 Million USD | -2965.437% |
| Lipocine Inc. | -17.93 Million USD | -2083.302% |
| Lexeo Therapeutics, Inc. Common Stock | -68.51 Million USD | -471.405% |
| Nautilus Biotechnology, Inc. | -76.15 Million USD | -414.086% |
| SAB Biotherapeutics, Inc. | -38.07 Million USD | -928.191% |
| G1 Therapeutics, Inc. | -39.52 Million USD | -890.429% |
| Bellerophon Therapeutics, Inc. | -22.38 Million USD | -1648.959% |
| Sage Therapeutics, Inc. | -579.84 Million USD | 32.485% |
| Ocugen, Inc. | -65.53 Million USD | -497.407% |
| Mind Medicine (MindMed) Inc. | -93.86 Million USD | -317.07% |
| Q32 Bio Inc. | -92.1 Million USD | -325.058% |
| Brainstorm Cell Therapeutics Inc. | -21.43 Million USD | -1726.051% |
| Alumis Inc. Common Stock | -158.17 Million USD | -147.504% |
| Equillium, Inc. | -14.52 Million USD | -2595.82% |
| Kyverna Therapeutics, Inc. | -62.4 Million USD | -527.323% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4853.432% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1975.191% |
| Galera Therapeutics, Inc. | -46.95 Million USD | -733.82% |
| Evelo Biosciences, Inc. | -108.46 Million USD | -260.931% |
| Comera Life Sciences Holdings, Inc. | -11.97 Million USD | -3170.564% |
| Dominari Holdings Inc. | -21.79 Million USD | -1696.141% |
| Edesa Biotech, Inc. | -9.22 Million USD | -4144.793% |
| vTv Therapeutics Inc. | -25.5 Million USD | -1435.123% |
| Bio-Techne Corporation | 206.68 Million USD | 289.411% |
| Harmony Biosciences Holdings, Inc. | 192.03 Million USD | 303.868% |
| Prelude Therapeutics Incorporated | -132.27 Million USD | -195.96% |
| Candel Therapeutics, Inc. | -38.39 Million USD | -919.736% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -159.09% |
| Nkarta, Inc. | -131.65 Million USD | -197.37% |
| BioCardia, Inc. | -11.64 Million USD | -3262.135% |
| Iterum Therapeutics plc | -47.46 Million USD | -724.739% |